Olympus to integrate UK businesses for medtech gain
This article was originally published in Clinica
In a bid to increase the strength of its healthcare offering, medtech giant Olympus is set to combine its UK operations under one management team. Olympus UK, which is based in Watford and focuses on camera, audio and life science sectors, and Olympus KeyMed, located in Southend-on-Sea and specialising in medical and industrial business, are currently individual segments of the company. This move will see Olympus KeyMed’s group managing director Paul Hillman become managing director of Olympus UK and Piers Devereux retain his role as joint managing director of Olympus UK. The firm said that Messrs Hillman and Devereux will work together to maximise the synergies that exist between the medical and life sciences businesses.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals